UPMC, GV, Gates Frontier back $51M financing round for drug discovery company

Pittsburgh-based UPMC Enterprises, GV (formerly Google Ventures), and Gates Frontier participated in the $51 million expansion series B financing round for drug discovery company Cerevance.

The company will use the financing to support clinical trials focusing on Parkinson's, amyotrophic lateral sclerosis and schizophrenia. 

The expansion brings the company's total series B financing round to $116 million, according to a Feb. 13 Cerevance news release provided to Becker's.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars